Login
$NRSN
$1.57 -$0.13 (7.4%) Live

Company Executives

Officer Age In this role Source
Alon Ben-Noon Also a director
Chief Executive Officer, Director
46 Since 2017
9 years
Or Eisenberg
Chief Financial Officer
44 Since 2021
5 years
Hagit Binder
Chief Operating Officer
47 Since 2023
3 years
Ferenc Tracik
Chief Medical Officer
62 Since 2021
5 years
Niva Russek-Blum
Chief Technology Officer
50 Since 2023
3 years

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the 20-F annual report

Directors
6
serving now
Independent
5 of 5
stated in the proxy; 1 not stated
Average tenure
2.0 years
from year joined
CEO also chairs the board
No
Mark Leuchtenberger
Director Age On board Independent Committees Pay Source
Mark Leuchtenberger
69 Not stated Independent None stated Not stated
Alon Ben-Noon
46 Not stated Not stated None stated Paid as CEO
Cary Claiborne
65 Not stated Independent
Audit Committee · Chair Compensation Committee
Not stated
Christine Pellizzari
58 Not stated Independent
Audit Committee Compensation Committee · Chair
Not stated
Roy Golan
52 2024
2 years
Independent
Audit Committee
Not stated
Revital Mandil-Levin
51 Not stated Independent
Compensation Committee
Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No proxy statement on record

Related-party transactions come from the company’s proxy statement. NeuroSense Therapeutics Ltd. has not filed one with the SEC.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support